Search - tctmd.com

Presenter: Ana Laynez, Rebecca Torguson, Camille Hauville, Gabriel Sardi, Itsik Ben-Dor, Gabriel Maluenda, Michael A. Gaglia, Manuel A. Gonzalez, Israel M. Barbash, Zhenyi Xue, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman

January 03, 2012

Advertisement

Se Publica el PRODIGY: No se observa Ventaja alguna a Largo Plazo con el Clopidogrel

PRODIGY Published: No Advantage to Long-term Clopidogrel

Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients

INFUSE-AMI: Bolus Abciximab Works, Thrombus Aspiration Doesn’t for Large STEMI

IABP Use Most Risky in ACS Patients Undergoing Urgent PCI

African-Americans Have Higher Bleeding Rates After Reperfusion for STEMI

Los Afroamericanos Tienen Índices de Hemorragia Más Altos tras la Reperfusión de un STEMI

Un Registro Confirma que en el ‘Mundo Real’ la Bivalirudina es Mejor contra el STEMI

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

HORIZONS-AMI: Radial Access PCI Reduces Bleeding, MACE in STEMI

HORIZONS-AMI: Las PCI mediante Acceso Radial Reducen las Hemorragias y los MACE en los STEMI

Meta-Analysis: Mixed Results Seen with First-Gen DES in STEMI Patients

Meta Análisis: Resultados Contradictorios con los SLF de 1ª Generación en Pacientes STEMI

Similar Mortality Rates Seen in Men and Women with NSTE ACS

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

Bivalirudin Therapy Is Associated with Improved Clinical and Economic Outcomes in STEMI Pts Undergoing PCI

El Tratamiento con Bivalirudina se Asocia a Mejores Resultados Clínicos y Económicos en Pacientes con STEMI Sometidos a PCI

Radial versus Femoral access approaches in percutaneous coronary intervention of patients receiving bivalirudin. On behalf of the EUROVISION Investigators. Martial Hamon,...

The Controlled Reperfusion with Bivalirudin and Intra Coronary Abciximab in the Porcine Mycoardial Infarction/Reperfusion Model

Safety and Efficacy for the Use of Prasugrel in Patients Undergoing Percutaneous Coronary Intervention and Anticoagulated with Bivalirudin.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content